Andrew Reaume
Amministratore Delegato presso Melior Discovery, Inc.
Posizioni attive di Andrew Reaume
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Amministratore Delegato | 01/01/2005 | - |
| Fondatore | 01/01/2005 | - | |
| Presidente | 01/01/2005 | - | |
Melior Pharmaceuticals I, Inc.
 Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | Presidente | 01/12/2008 | - |
| Fondatore | 01/12/2008 | - | |
| Amministratore Delegato | 01/12/2008 | - |
Storia della carriera di Andrew Reaume
Precedenti posizioni note di Andrew Reaume
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/01/1993 | 01/01/1999 |
| ADHERA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 09/09/2021 | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formazione di Andrew Reaume
| University of Connecticut | Doctorate Degree |
| University of Pennsylvania | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 3 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | Health Technology |
- Borsa valori
- Insiders
- Andrew Reaume
- Esperienza
